Prof. Dr. Katja Schenke-Layland

seit 2018 Direktorin, NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Deutschland

seit 2018 Co-Editor-in-Chief, Tissue Engineering, Part B (Mary Ann Liebert)

seit 2011 Ordentliche Professorin (W3), Eberhard Karls Universität Tübingen (EKUT), Abt. Frauengesundheit, Forschungsinstitut für Frauengesundheit, Tübingen, Deutschland

seit 2012 Executive Editor, Advanced Drug Delivery Reviews (ADDR) (Elsevier)

seit 2018 Project Scientist, University of California Los Angeles (UCLA), Dept. of Medicine/ Cardiology, Cardiovascular Research Laboratories (CVRL), Los Angeles, CA, USA

2013-2018 Adjunct Associate Professor, UCLA, Dept. of Medicine/ Cardiology, Los Angeles, CA, USA

2016-2017 Direktorin (interim., geschäftsführend), Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik (IGB), Stuttgart, Deutschland

2013-2017 Abteilungsleiterin, Fraunhofer IGB, Abteilung Zell- und Tissue Engineering, Stuttgart, Deutschland

2010-2013 Visiting Associate Professor, UCLA, Dept. of Medicine/ Cardiology, Los Angeles, CA, USA

2010-2014 ATTRACT-Gruppenleiterin, Fraunhofer IGB, Stuttgart, Deutschland

2010-2013 Stellvertretende Abteilungsleiterin, Fraunhofer IGB, Abt. Zell- und Tissue Engineering, Stuttgart, Deutschland

2008-2009 Assistant Research Professor, UCLA, Dept. of Medicine/ Cardiology, Los Angeles, CA, USA

2005-2008 Postdoctoral Research Fellow, UCLA, Cardiovascular Research Laboratories, Los Angeles/CA, USA

2004-2005 Postdoctoral Research Fellow, Children's Hospital Los Angeles, Saban Research Institute, Los Angeles/CA, USA

2001-2004 Promotion in Biologie/ Cardiovascular Tissue Engineering, Friedrich-Schiller-Universität (FSU) Jena, Deutschland

1995-2000 M.Sc. in Biologie, Soziologie, Psychologie, Friedrich-Schiller-Universität (FSU) Jena, Deutschland

 

Weitere Infos: Schenke-Layland Lab

 

Prof. Dr. Katja Schenke-Layland
Institutsleiterin
T +49 (0)7121 51530-10
F +49 (0)7121 51530-16

Publikationen

  • Generation and characterization of the human induced pluripotent stem cell line NMIi010-A from peripheral blood mononuclear cells of a healthy 49–year old male individual
    Keller AK, Binner A, Breitmeyer R, Vogel S, Anderle N, Rothbauer U, Schenke-Layland K, Schmees C
    Stem Cell Research Volume 54, July 2021, 102427, https://doi.org/10.1016/j.scr.2021.102427
  • Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
    Becker M, Dulovic A, Junker D, Ruetalo N, PKaiser PD, Pinilla YT, Heinzel C, Haering J, Traenkle B, Wagner TR, Layer M, Mehrlaender M, Mirakaj V, Held J, Planatscher H, Schenke-Layland K, Krause G, Strengert M, Bakchoul T, Althaus K, Fendel R, Kreidenweiss A, Koeppen M, Rothbauer U, Schindler M & Schneiderhan-Marra N
    NATURE COMMUNICATIONS| (2021) 12:3109 | https://doi.org/10.1038/s41467-021-23473-6 | www.nature.com/naturecommunications11234567890():,;
  • Towards automation in biologics production via Raman micro-spectroscopy, laser-induced forward cell transfer and surface-enhanced Raman spectroscopy
    Jaeckle E, Brauchle E, Nottrodt N, Wehner M, Lensing R, Gillner A, Schenke-Layland K, Bach M, Burger-Kentischer A
    Journal of Biotechnology Volume 323, 10 November 2020, Pages 313-321 https://doi.org/10.1016/j.jbiotec.2020.09.001
  • HepaChip-MP – a twenty-four chamber microplate for a continuously perfused liver coculture model
    Busche M, Tomilova O, Schütte J, Werner S, Beer M, Groll N, Hagmeyer B, Pawlak M, Jones P D, Schmees C, Becker H, Schnabel J, Gall K, Hemmler R, Matz-Soja M, Damm G, Beuck S, Klaassen T, Moer J, Ullrich A, Runge D, Schenke-Layland K, Gebhardt R und Stelzle M
    Lab on a Chip, DOI: 10.1039/d0lc00357c
  • Imaging fibrosis in inflammatory diseases: Targeting exposed extracellular matrix
    Beziere N, Fuchs K, Maurer A, Reischl B, Brück J, Ghoreschi K, Carvajal Berrio D, Schenke-Layland K, Kohlhofer U, Quintanilla-Martinez L, Gawaz M, Kneilling M, Pichler B
    Theranostics in press
  • Comparative study of MSCA-1 and CD146 isolated periosteal cell subpopulations
    Umrath F, Thomalla C, Pöschel S, Schenke-Layland K, Reinert S, Alexander D
    Cell Physiol Biochem. 2018;51(3):1193-1206. doi: 10.1159/000495497. Epub 2018 Dec 12.
  • Stem cell-based organ-on-a-chip models for diabetes research
    Rogal J, Zbinden A, Schenke-Layland K, Loskill P
    Adv Drug Deliv Rev 2018 in press (Review)
  • Non-invasive characterization of hybrid gelatin: poly-L-lactide electrospun scaffolds with controlled structural properties using second harmonic generation and multiphoton imaging
    Piccirillo G, Ditaranto MV, Feuerer NFS, Carvajal Berrio DA, Brauchle EM, Pepe A, Bochicchioa B, Schenke-Layland K, Hinderer S
    Journal of Materials Chemistry B. 2018 Sept; 6(40): 6399-6412. DOI: 10.1039/c8tb02026d.
  • Improved long-term durability of allogeneic heart valves in the orthotopic sheep model
    Biermann AC, Marzi J, Brauchle E, Wichmann JL, Arendt CT, Puntmann V, Nagel E, Abdelaziz S, Winter AG, Brockbank KGM, Layland S, Schenke-Layland K, Stock UA
    Eur J Cardiothorac Surg. 2018 Aug 24. doi: 10.1093/ejcts/ezy292. [Epub ahead of print]
  • Biomechanical and biomolecular characterization of ECM in human colon carcinomas
    Brauchle E, Kasper J, Daum R, Schierbaum N, Falch C, Kirschniak A, Schäffer T, Schenke-Layland K
    Matrix Biol. 2018 Aug;68-69:180-193. doi: 10.1016/j.matbio.2018.03.016. Epub 2018 Mar 29.
  • Influence of aflibercept on platelet activation profile
    Sobolewska B, Golenko J, Poeschel S, Grimmel C, Gatsiou A, Sopova K, Biedermann T, Schenke-Layland K, Stellos K, Ziemssen F
    Exp Eye Res. 2018 Oct; 175:166-172. doi: 10.1016/j.exer.2018.06.009. Epub 2018 Jun 15. PMID: 29908884.
  • Steps toward Maturation of Embryonic Stem Cell-Derived Cardiomyocytes by Defined Physical Signals
    Shen N, Knopf A, Westendorf C, Kraushaar U, Riedl J, Bauer H, Poschel S, Layland SL, Holeiter M, Knolle S, Brauchle E, Nsair A, Hinderer S, Schenke-Layland K
    Stem Cell Reports. 2017 Jul 11;9(1):122-135. doi: 10.1016/j.stemcr.2017.04.021. Epub 2017 May 18.
  • Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
    Becker M, Dulovic A, Junker D, Ruetalo N, PKaiser PD, Pinilla YT, Heinzel C, Haering J, Traenkle B, Wagner TR, Layer M, Mehrlaender M, Mirakaj V, Held J, Planatscher H, Schenke-Layland K, Krause G, Strengert M, Bakchoul T, Althaus K, Fendel R, Kreidenweiss A, Koeppen M, Rothbauer U, Schindler M & Schneiderhan-Marra N
    NATURE COMMUNICATIONS| (2021) 12:3109 | https://doi.org/10.1038/s41467-021-23473-6 | www.nature.com/naturecommunications11234567890():,;